Legal & General Group PLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $94,072 - $98,836	-649 Reduced 0.74%	86,684 $13.1 Million
Q2 2022 Aug 22, 2022	BUY	$83.14 - $145.99 $2.69 Million - $4.72 Million	32,299 Added 58.69%	87,333 $12.7 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $299,527 - $388,885	2,721 Added 5.2%	55,034 $6.53 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $340,577 - $507,059	3,415 Added 6.98%	52,313 $7.21 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $1.19 Million - $1.67 Million	12,031 Added 32.63%	48,898 $6.79 Million
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $203,391 - $324,721	3,092 Added 9.15%	36,867 $3.58 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $14,223 - $20,368	222 Added 0.66%	33,775 $2.31 Million
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $8,328 - $12,574	-128 Reduced 0.38%	33,553 $2.88 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $184,322 - $243,359	3,122 Added 10.22%	33,681 $2.19 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $107,337 - $274,651	3,700 Added 13.78%	30,559 $2.23 Million
Q1 2020 May 14, 2020	SELL	$27.51 - $57.29 $125,940 - $262,273	-4,578 Reduced 14.56%	26,859 $914,000
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $37,672 - $53,153	922 Added 3.02%	31,437 $1.71 Million
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $544,215 - $720,233	14,559 Added 91.24%	30,515 $1.27 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $37,283 - $62,788	937 Added 6.24%	15,956 $698,000
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $336,052 - $518,778	9,735 Added 184.24%	15,019 $773,000
Q4 2018 Feb 15, 2019	BUY	$29.75 - $42.9 $19,397 - $27,970	652 Added 14.08%	5,284 $196,000
Q3 2018 Nov 20, 2018	BUY	$32.79 - $43.0 $7,049 - $9,245	215 Added 4.87%	4,632 $174,000
Q2 2018 Aug 10, 2018	SELL	$23.62 - $42.29 $28,556 - $51,128	-1,209 Reduced 21.49%	4,417 $175,000
Q1 2018 May 17, 2018	BUY	$22.49 - $34.56 $66,637 - $102,401	2,963 Added 111.27%	5,626 $145,000
Q4 2017 Feb 13, 2018	BUY	$20.44 - $35.56 $54,431 - $94,696	2,663	2,663 $72,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account